Skip to content

ANAPA® vs PAINSTOP® after laparoscopic gynecologic surgery

Comparative study on the patient-controlled analgesia infuion pump PAINSTOP and ANANPA after laparoscopic gynecological surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003633
Enrollment
232
Registered
2019-03-18
Start date
2018-03-14
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : In total, 211 patients were randomized to ANAPA (n = 106, Group A) or PAINSTOP (n = 105, Group P) postoperative pain treatment groups. For group ANAPA group, 700 mcg of fentanyl, 150
the background infusion rate was set to 2 ml/h and the bolus dose to 0.5 mL, and a 15-min lockout interval was applied. For group PAINASTOP group, the background infusion rate was set to 6 ml/h, the b

Sponsors

Soon Chun Hyang University Hospital Cheonan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The adult patients were between the ages of 18 and 65 years, with American Society of Anesthesiologists (ASA) physical status of 1 or 2, and had requested postoperative IV-PCA for laparoscopic gynecologic surgery scheduled to be performed at our hospital.

Exclusion criteria

Exclusion criteria: Patients with a history of COPD, traumatic head injury, hepatitis, or renal failure; those with habitual sedative or other drug use; those with psychiatric disease; and those who were inappropriate candidates for IV-PCA were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting incidence

Secondary

MeasureTime frame
the quantity of analgesics used by each patient, the administration of additional analgesics, background infusion rate, Numerical rating scale, the sedation level, and other side effects

Countries

Korea, Republic of

Contacts

Public ContactNan Seol Kim

Soon Chun Hyang University Hospital Cheonan

nskim1977@naver.com+82-41-570-2829

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026